The advancements made in treating eye disease over the past decade have seen outstanding results, with significant progress being made for age-related macular degeneration, glaucoma and diabetic macular edema. This is still the beginning and we remain committed to clinical operations with a therapeutic focus on ophthalmology studies via our experienced project teams. Ensuring the improvement of eye health through both biopharmaceutical and medical device and diagnostic development.

Areas of expertise include

  • Cataract
  • Choroideremia
  • Conjuctivitis
  • Diabetic macular edema
  • Dry eye
  • Eyelash hypotrichosis
  • Glaucoma/OHT
  • Macular degeneration
  • Macular edema
  • Optic neuropathy
  • Retinal detachment
  • Uveitis
  • Vitreomacular adhesion